Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Shandong Weigao Group Medical Polymer Co ( (HK:1066) ).
Shandong Weigao Group Medical Polymer Company Limited has announced a rescheduling of its extraordinary general meeting (EGM) from October 16, 2025, to October 17, 2025, to allow more time for finalizing the circular to be sent to shareholders. The book closure period for determining shareholders’ entitlement to attend and vote at the EGM has also been adjusted, impacting the timeline for share transfers and dividend entitlements.
The most recent analyst rating on (HK:1066) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in the People’s Republic of China. It operates in the medical polymer industry, focusing on the production and distribution of medical devices and related products.
Average Trading Volume: 14,960,364
Technical Sentiment Signal: Hold
Current Market Cap: HK$26.27B
See more data about 1066 stock on TipRanks’ Stock Analysis page.